SEC Form 4 · accession 0000899243-19-005943
Allena Pharmaceuticals, Inc. · ALNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward Wholihan
Officer — Chief Financial Officer
Period of report
Mar 4, 2019
Accepted (ET)
Mar 4, 2019 · 7:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001624658
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.70 | Mar 4, 2019 | A | 125,000 | A | — | Mar 4, 2029 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F1Stock option shall vest and become exercisable in 48 equal monthly installments beginning on the one month anniversary of February 19, 2019.